Oslo Medicines Initiative policy brief

Established in 2020, the Oslo Medicines Initiative (OMI) is a collaboration between the WHO Regional Office for Europe, the Norwegian Ministry of Health and Care Services and the Norwegian Medicines Agency. The OMI has provided a neutral platform for the public and private sectors jointly to outline a vision for equitable and sustainable access to and affordability of effective, novel and high-priced medicines. This policy brief draws on the analyses and policy considerations that have emerged from the work undertaken through the OMI, including a series of commissioned technical reports. A product life-cycle approach has been used to explore specific responsibilities and corresponding policy options available to governments and other stakeholders. This policy brief highlights opportunities for further work to design and implement policies and supporting tools that promote sustainable access to affordable, effective novel medicines.

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.

Jane H. Mashingia and colleagues reveal the progress made to date for the East African Community Medicines Regulatory Harmonization initiative.